This inventor holds 1 USPTO granted patent, plus 4 CIPO patents and 1 EPO patent. Top assignee: Gilead Apollo, LLC. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Kyle Sabourin
Introduction
Kyle Sabourin is an accomplished inventor based in Foster City, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Acetyl CoA Carboxylase (ACC). Her work is crucial in addressing ACC-mediated diseases, showcasing her dedication to advancing medical treatments.
Latest Patents
Kyle holds a patent for "Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof." This invention provides solid forms of compounds that are useful as inhibitors of ACC, along with methods for their production and application in treating related diseases. She has 1 patent to her name, reflecting her innovative approach to solving complex medical challenges.
Career Highlights
Kyle is currently employed at Gilead Apollo, LLC, where she continues to push the boundaries of pharmaceutical research. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to groundbreaking advancements in medicine.
Collaborations
Throughout her career, Kyle has worked alongside notable colleagues such as Selcuk Calimsiz and Michael Geier. These collaborations have enriched her research and expanded the impact of her inventions.
Conclusion
Kyle Sabourin's innovative work in developing ACC inhibitors exemplifies her commitment to improving healthcare through scientific advancements. Her contributions are vital in the ongoing fight against ACC-mediated diseases, and her career continues to inspire future generations of inventors.